Organization

Semmelweis University

8 clinical trials

4 abstracts

Abstract
CancerHallmarks.com: A tool for the enrichment analysis of the cancer hallmarks.
Org: Semmelweis University, Budapest, Hungary, Semmelweis Egyetem Pulmonologiai Klinika, Seagen, Inc.,
Clinical trial
The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate
Status: Recruiting, Estimated PCD: 2027-12-01
Abstract
Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma.
Org: IRCCS Humanitas Research Hospital, Rozzano, Italy, Humanitas University, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki University Hospital Comprehensive Cancer Center, Semmelweis University,
Abstract
Five-year subgroup analysis of tafasitamab + lenalidomide from the phase II L-MIND study in patients with relapsed or refractory diffuse large B-cell lymphoma.
Org: Vall d’Hebron Institute of Oncology (VHIO), Ludwig-Maximilians-University Hospital, University of Eastern Piedmont, Institut Català D'Oncologia, IDIBELL,
Clinical trial
Investigation of Endothelium-dependent Vasodilation in Human Gingiva Depending on Serum Estrogen Level
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
PAT12-730DS
Status: Completed, Estimated PCD: 2013-09-01